Showing results (541-550 of 631) with videos related to
Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypesHiroko Masuda, Keith A Baggerly, Ying Wang, et al.Endocrinology|November 12, 2010
Regulation of placental growth by aldosterone and cortisolCarine Gennari-Moser, Eliyahu V Khankin, Simone Schüller, et al.Science Signaling|February 4, 2016
Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylationNao Iwamoto, Lorenza A D'Alessandro, Sofia Depner, et al.Investigative Radiology|July 19, 2005
Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparisonRui Sun, Julia Dittrich, Martin Le-Huu, et al.Clinical and Experimental Immunology|November 19, 2016
Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New GuineaJ P Francis, P C Richmond, D Strickland, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancerKe-Da Yu, Rui Zhu, Ming Zhan, et al.Plos One|April 17, 2020
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsetsOlga Y Korolkova, Sarrah E Widatalla, Diva S Whalen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2005
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variationC Holmes, C Ballard, D Lehmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionKatherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.Pageof 64